Caption Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-55,700
| Closed | -$36.5K | – | 957 |
|
2025
Q1 | $36.5K | Buy |
+55,700
| New | +$36.5K | ﹤0.01% | 480 |
|
2023
Q1 | – | Sell |
-28,100
| Closed | -$88.2K | – | 762 |
|
2022
Q4 | $88.2K | Buy |
+28,100
| New | +$88.2K | ﹤0.01% | 348 |
|
2022
Q3 | – | Sell |
-44,100
| Closed | -$183K | – | 846 |
|
2022
Q2 | $183K | Hold |
44,100
| – | – | ﹤0.01% | 366 |
|
2022
Q1 | $257K | Sell |
44,100
-2,376
| -5% | -$13.8K | ﹤0.01% | 374 |
|
2021
Q4 | $349K | Buy |
46,476
+21,376
| +85% | +$161K | ﹤0.01% | 398 |
|
2021
Q3 | $226K | Buy |
25,100
+2,335
| +10% | +$21K | ﹤0.01% | 420 |
|
2021
Q2 | $273K | Sell |
22,765
-46,441
| -67% | -$557K | ﹤0.01% | 318 |
|
2021
Q1 | $867K | Buy |
69,206
+62,206
| +889% | +$779K | 0.02% | 174 |
|
2020
Q4 | $109K | Buy |
+7,000
| New | +$109K | ﹤0.01% | 261 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 604 |
|
2020
Q2 | – | Sell |
-25,000
| Closed | -$160K | – | 582 |
|
2020
Q1 | $160K | Buy |
+25,000
| New | +$160K | 0.01% | 234 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 502 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 451 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 415 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 363 |
|
2018
Q3 | – | Sell |
-61,667
| Closed | -$876K | – | 354 |
|
2018
Q2 | $876K | Buy |
+61,667
| New | +$876K | 0.07% | 76 |
|